Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 20

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 20
---
 day is also the Fixed Purchase Date for a Fixed Purchase of an amount of Depositary
Shares not less than the applicable Fixed Purchase Maximum Amount (calculated as of the applicable Fixed Purchase Date), we may also direct
the Selling Shareholder, by delivery of a VWAP Purchase Notice, to purchase, on the VWAP Purchase Date, an additional number of Depositary
Shares at a purchase price equal to the lesser of 95% of (i) the closing price of a Depositary Share on the trading day immediately preceding the applicable VWAP Purchase Date and (ii) the VWAP during the period on the applicable VWAP Purchase Date beginning at the opening of trading and ending at the VWAP Purchase Termination Time (as defined in the Purchase Agreement).

At any time from and after
the Commencement Date, on any business day that is also the VWAP Purchase Date for a VWAP Purchase, we may also direct the Selling Shareholder,
by delivery of an Additional VWAP Purchase Notice, to purchase, on the same business day, an additional number of Depositary Shares at
a purchase price equal to the lesser of 95% of (i) the closing price of a Depositary Share on the trading day immediately preceding the applicable Additional VWAP Purchase Date and (ii) the VWAP during the Additional VWAP Purchase Period (as defined in the Purchase Agreement) on the applicable Additional VWAP Purchase Date.

Notwithstanding the above,
in no event may the aggregate amount of Purchase Shares submitted in any single or combination of VWAP Purchase Notices and/or Additional
VWAP Purchase Notices on a particular date require a payment from the Selling Shareholder to us that exceeds $2,500,000, unless such limitation
is waived by the Selling Shareholder.

For purposes of the Purchase
Agreement, “VWAP” shall mean the daily volume weighted average price of the Depositary Shares on Nasdaq as reported by Bloomberg
through its “AQR” function.

All such determinations shall
be appropriately adjusted for any sales of Depositary Shares through block transactions, any reorganization, non-cash dividend, stock
split, reverse share split, stock combination, recapitalization, Depositary Share-Ordinary Share ratio change or other similar transaction
during such period.

Commitment Fee, Commitment Shares and Other Fees

As consideration for its irrevocable
commitment to purchase our Depositary Shares under the Purchase Agreement, we have agreed to pay to the Selling Shareholder the Commitment
Fee as